427 related articles for article (PubMed ID: 32132993)
1. Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity.
Suryawanshi A; Hussein MS; Prasad PD; Manicassamy S
Front Immunol; 2020; 11():122. PubMed ID: 32132993
[TBL] [Abstract][Full Text] [Related]
2. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.
Li X; Xiang Y; Li F; Yin C; Li B; Ke X
Front Immunol; 2019; 10():2293. PubMed ID: 31616443
[TBL] [Abstract][Full Text] [Related]
3. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.
Fu C; Jiang A
Front Immunol; 2018; 9():3059. PubMed ID: 30619378
[TBL] [Abstract][Full Text] [Related]
4. Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation.
Suryawanshi A; Manoharan I; Hong Y; Swafford D; Majumdar T; Taketo MM; Manicassamy B; Koni PA; Thangaraju M; Sun Z; Mellor AL; Munn DH; Manicassamy S
J Immunol; 2015 Apr; 194(7):3295-304. PubMed ID: 25710911
[TBL] [Abstract][Full Text] [Related]
5. Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response.
Garris CS; Luke JJ
Clin Cancer Res; 2020 Aug; 26(15):3901-3907. PubMed ID: 32332013
[TBL] [Abstract][Full Text] [Related]
6. Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy.
Wang B; Tian T; Kalland KH; Ke X; Qu Y
Trends Pharmacol Sci; 2018 Jul; 39(7):648-658. PubMed ID: 29678298
[TBL] [Abstract][Full Text] [Related]
7. β-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8⁺ T cells.
Liang X; Fu C; Cui W; Ober-Blöbaum JL; Zahner SP; Shrikant PA; Clausen BE; Flavell RA; Mellman I; Jiang A
J Leukoc Biol; 2014 Jan; 95(1):179-90. PubMed ID: 24023259
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling pathway in cancer immunotherapy.
Zhou Y; Xu J; Luo H; Meng X; Chen M; Zhu D
Cancer Lett; 2022 Jan; 525():84-96. PubMed ID: 34740608
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy.
Peng X; He Y; Huang J; Tao Y; Liu S
Front Immunol; 2021; 12():613492. PubMed ID: 33732237
[TBL] [Abstract][Full Text] [Related]
10. Role of dendritic cell metabolic reprogramming in tumor immune evasion.
Plebanek MP; Sturdivant M; DeVito NC; Hanks BA
Int Immunol; 2020 Jun; 32(7):485-491. PubMed ID: 32449776
[TBL] [Abstract][Full Text] [Related]
11. Generation of tolerogenic dendritic cells via the E-cadherin/beta-catenin-signaling pathway.
Fu C; Jiang A
Immunol Res; 2010 Mar; 46(1-3):72-8. PubMed ID: 19771400
[TBL] [Abstract][Full Text] [Related]
12. β-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cells.
Hong Y; Manoharan I; Suryawanshi A; Majumdar T; Angus-Hill ML; Koni PA; Manicassamy B; Mellor AL; Munn DH; Manicassamy S
Cancer Res; 2015 Feb; 75(4):656-665. PubMed ID: 25568183
[TBL] [Abstract][Full Text] [Related]
13. Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights.
Patel S; Alam A; Pant R; Chattopadhyay S
Front Immunol; 2019; 10():2872. PubMed ID: 31921137
[TBL] [Abstract][Full Text] [Related]
14. Wnt signaling in dendritic cells: its role in regulation of immunity and tolerance.
Swafford D; Manicassamy S
Discov Med; 2015 Apr; 19(105):303-10. PubMed ID: 25977193
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic β-catenin signaling suppresses CD8
Xue J; Yu X; Xue L; Ge X; Zhao W; Peng W
Biomed Pharmacother; 2019 Jul; 115():108921. PubMed ID: 31078045
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment-related dendritic cell deficiency: a target to enhance tumor immunotherapy.
Zhu S; Yang N; Wu J; Wang X; Wang W; Liu YJ; Chen J
Pharmacol Res; 2020 Sep; 159():104980. PubMed ID: 32504832
[TBL] [Abstract][Full Text] [Related]
17. Wnt/beta-catenin pathway: modulating anticancer immune response.
Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-214 induces dendritic cell switching from tolerance to immunity by targeting β-Catenin signaling.
Gu C; Zhou XD; Yuan Y; Miao XH; Liu Y; Ru YW; Li KQ; Li G
Int J Clin Exp Pathol; 2015; 8(9):10050-60. PubMed ID: 26617712
[TBL] [Abstract][Full Text] [Related]
19. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine.
Manicassamy S; Reizis B; Ravindran R; Nakaya H; Salazar-Gonzalez RM; Wang YC; Pulendran B
Science; 2010 Aug; 329(5993):849-53. PubMed ID: 20705860
[TBL] [Abstract][Full Text] [Related]
20. The role of dendritic cells in cancer.
Hansen M; Andersen MH
Semin Immunopathol; 2017 Apr; 39(3):307-316. PubMed ID: 27638181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
